[ad_1] PARIS, Nov 27 (Reuters) – The number of patients admitted to intensive care in France for a coronavirus infection dropped below 4,000 on Friday for the first time since Nov 3, with 3,883 beds occupied, according to the report. newspaper communicated by the authorities. The total number of hospitalized …
Read More »Roche: new indication for Xofluza
[ad_1] (CercleFinance.com) – Roche announces that the US FDA has approved an additional authorization application for Xofluza, as a treatment to prevent influenza in people 12 years of age and older who have been in contact with people with the flu. With this decision, which is based on the Phase …
Read More »Coronavirus-Germany could launch a vaccination campaign in December
[ad_1] FRANKFURT, Nov. 23 (Reuters) – Germany could start administering doses of the COVID-19 vaccine as early as next month, Health Minister Jens Spahn said, according to comments reported by the press group on Monday. RedaktionsNetzwerk Deutschland. “There are reasons to be optimistic about vaccine approval in Europe this year,” …
Read More »Roche’s arthritis treatment is quite effective for COVID-19, according to one study
[ad_1] A ROCKY TREATMENT AGAINST ARTHRITIS EFFECTIVE ENOUGH COVID-19, STUDY ZURICH (Reuters) – Actemra, a Roche drug originally targeted for arthritis, has shown some efficacy in treating COVID-19 in a study involving 303 patients, a study author said Thursday. This anti-inflammatory drug, also called tocilizumab, has achieved an “important efficacy …
Read More »AstraZeneca: Confirmed strong immune response in older people for the COVID vaccine
[ad_1] ASTRAZENECA: STRONG IMMUNE RESPONSE CONFIRMED IN THE MOST ANCIENT FOR THE ANTI-COVID VACCINE par Kate Kelland LONDON (Reuters) – The COVID-19 vaccine candidate developed by AstraZeneca and the University of Oxford elicits a strong immune response in the elderly, the results of a mid-stage study published Thursday in The …
Read More »AstraZeneca-Strong immune response confirmed in the elderly for the COVID vaccine
[ad_1] par Kate Kelland LONDON, Nov 19 (Reuters) – The COVID-19 vaccine candidate developed by AstraZeneca and the University of Oxford causes a strong immune response in the elderly, mid-phase study results published Thursday in the medical journal The Lancet. According to the study, a preliminary version of which was …
Read More »Coronavirus-Spain records more than 21,000 new cases in 24 hours
[ad_1] MADRID, Nov. 13 (Reuters) – Spain recorded 21,371 new cases of COVID-19 contamination in 24 hours, bringing the toll to 1,458,591 cases since the outbreak in the country, according to data provided Friday by the Ministry of Health. Health authorities also reported 1,315 virus deaths in the past seven …
Read More »